Study of the Effects of Obeticholic Acid on Farnesoid X Receptor Expression in Jejunum and on Gut Microbiota in Morbidly Obese Patients and Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 20 Oct 2016
At a glance
- Drugs Obeticholic acid (Primary)
- Indications Obesity
- Focus Pharmacodynamics
- Acronyms OCAPUSH
- 10 Jun 2017 Biomarkers information updated
- 15 Oct 2016 Planned End Date changed from 1 Apr 2017 to 1 Oct 2017.
- 15 Oct 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Oct 2017.